Acute recurrent pancreatitis complicated by pseudocyst status post AXIOS stent placement for drainage. Reevaluate pseudocyst. ABDOMEN:LIVER, BILIARY TRACT: No focal lesion biliary ductal dilatation or vascular abnormality. Normally distended gallbladder.SPLEEN: No significant abnormality noted.PANCREAS: Compared to the CT dated 4/27/2016 there has been marked decrease in size of the intraparenchymal pancreatic fluid collection with the gastrocystostomy stent device in place. There appears to be a percutaneous drain as well extending through the left upper quadrant into the stomach and terminating near the catheter device. The proximal and distal main pancreatic duct is normal in caliber.There is significant atrophy of the pancreatic body which is replaced by inflammatory/necrotic tissue. The pancreatic duct is not visualized at this level without upstream dilatation.Normal intrinsic T1-weighted signal intensity of the pancreatic head and uncinate process. Moderately decreased intrinsic T1-weighted signal intensity of the body and tail of the pancreas. The residual parenchyma demonstrates postcontrast enhancement. No evidence of acute peripancreatic inflammatory changes.Moderate narrowing of the portal vein confluence with opacification of the portal vein. The splenic vein is attenuated but opacified.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral simple appearing cysts. No hydroureteronephrosis.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Compared to the 4/27/2016 CT the fluid collection in the pancreatic body has essentially resolved. Significant atrophy of the pancreatic body which is replaced by inflammatory/necrotic tissue without visualization of the pancreatic duct at this level. No upstream pancreatic ductal dilatation.2.No new fluid collection or evidence of acute pancreatitis.